The Artelon extremities tissue implant is acquired and brought to US

Artelon® Product Line Under New Ownership, Relocates Operations from Sweden to U.S. (press release) International Life Sciences, LLC (dba, Artelon®) acquired the assets of Artimplant® AB in January 2014 and has relocated operations from Sweden to the United States.  This international relocation allows Artelon® to more closely engage its largest customer base and provide additional opportunities for product development that were not previously available. Adam Barese now serves as the Chief Executive Officer of the Organization.  After garnering almost two decades of medical industry experience...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top